Let’s get ready to reconnect in Melbourne, Australia! We’re on a mission to change the way the world sees the genome with genome mapping systems, nucleic acid purification solutions, analysis software, and clinical testing services. Come explore the genomic variation continuum, from SNVs to whole chromosomes, through our solutions. Together, we can reveal more variation that matters in cancer research.
This year’s ICG conference offers multiple opportunities to hear how optical genome mapping (OGM) from Bionano is uncovering cancer genomic variation that other methods can’t. Come and learn how we’re impacting oncology research.
Wednesday, 19 July 2023
7:00 AM - 8:00 AM
This Bionano Industry Symposium features invited speaker Dr. Naomichi Matsumoto, Professor, Human Genetics, Yokohama City University, Japan, who will speak on the application of Optical genome mapping to enhance the understanding of disease genomes. Dr. Matsumoto completed his MD at Kyushu University and his PhD at Nagasaki University in Japan. He conducted his postdoctoral training at the University of Chicago. Dr. Matsumoto is currently Full Professor and Chair of Human Genetics at Yokohama City University in Japan. He is a council member of the Japan Society of Human Genetics, has published over 750 papers and served as an Editor-in-Chief for the Journal of Human Genetics (Springer Nature Publishing) from 2014 – 2020. He could successfully isolate more than 80 genes associated with various genetic disorders including NSD1, STXBP1, SPTAN1, NOTCH2NLC and many others. He is an awardee of the Japan Society of Human Genetics Award for Young Scientists (2003), the Japan Society of Human Genetics Award (2011) and A Prize for Science and Technology, Research Category, The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology (2019).
Following Prof. Matsumoto’s talk, Nandita Mullapudi, Market Development Manager APAC, Bionano, will present a demonstration of Bionano VIA™ software, showcasing its latest features enabling the integrated Visualization, Interpretation and Analysis of cytogenomic and NGS data, resulting in a truly comprehensive view of genomic aberrations in a sample.
If you’re curious about OGM and wondering how it connects to your work, stop by and talk to one of our dedicated team members. We can’t wait to share our enthusiasm for technology that is moving clinical research forward in remarkable ways.